Search research articles
Contact Us
Filters
Showing results (141-150 of 295) with videos related to
Page
of 30
Sort By:
Cancer Science
|
July 13, 2004
Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
Tetsuya Hamaguchi, Yasuhiro Matsumura, Yukihiro Nakanishi, et al.
Scientific Reports
|
October 20, 2023
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study
Mamiko Shiroyama, Shota Fukuoka, Toshiki Masuishi, et al.
Annals of Gastroenterological Surgery
|
May 28, 2019
Risk factors for early postoperative complications after D3 dissection for stage II or III colon cancer: Supplementary analysis of a multicenter randomized controlled trial in Japan (JCOG0404)
Yusuke Nishizawa, Tomonori Akagi, Masafumi Inomata, et al.
World Journal of Surgery
|
March 8, 2018
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, et al.
Journal of Neuro-Oncology
|
December 2, 2008
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors
Fusako Waki, Masashi Ando, Atsuo Takashima, et al.
Journal of Clinical Medicine
|
November 26, 2022
Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
Takehiro Okabayashi, Kenta Sui, Motoyasu Tabuchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 8, 2010
Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
Daisuke Takahari, Yasuhiro Shimada, Shigeyuki Takeshita, et al.
Anesthesiology
|
May 26, 2005
Opposing effects of isoflurane and sevoflurane on neurogenic pulmonary edema development in an animal model
Nobuhisa Kandatsu, Yong-Shan Nan, Guo-Gang Feng, et al.
Japanese Journal of Clinical Oncology
|
February 27, 2003
A Phase II study of irinotecan in combination with 120-h infusion of 5-fluorouracil in patients with metastatic colorectal carcinoma: Japan Clinical Oncology Group Study (JCOG9703)
Atsushi Ohtsu, Narikazu Boku, Takashi Yoshioka, et al.
International Journal of Clinical Oncology
|
March 15, 2012
Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer
Natsuko Hori, Satoru Iwasa, Hironobu Hashimoto, et al.
Page
of 30
Search research articles
Search
Showing results (141-150 of 295) with videos related to
Sort By:
Page
of 30
Cancer Science
|
July 13, 2004
Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
Tetsuya Hamaguchi, Yasuhiro Matsumura, Yukihiro Nakanishi, et al.
Scientific Reports
|
October 20, 2023
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study
Mamiko Shiroyama, Shota Fukuoka, Toshiki Masuishi, et al.
Annals of Gastroenterological Surgery
|
May 28, 2019
Risk factors for early postoperative complications after D3 dissection for stage II or III colon cancer: Supplementary analysis of a multicenter randomized controlled trial in Japan (JCOG0404)
Yusuke Nishizawa, Tomonori Akagi, Masafumi Inomata, et al.
World Journal of Surgery
|
March 8, 2018
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, et al.
Journal of Neuro-Oncology
|
December 2, 2008
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors
Fusako Waki, Masashi Ando, Atsuo Takashima, et al.
Journal of Clinical Medicine
|
November 26, 2022
Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
Takehiro Okabayashi, Kenta Sui, Motoyasu Tabuchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 8, 2010
Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
Daisuke Takahari, Yasuhiro Shimada, Shigeyuki Takeshita, et al.
Anesthesiology
|
May 26, 2005
Opposing effects of isoflurane and sevoflurane on neurogenic pulmonary edema development in an animal model
Nobuhisa Kandatsu, Yong-Shan Nan, Guo-Gang Feng, et al.
Japanese Journal of Clinical Oncology
|
February 27, 2003
A Phase II study of irinotecan in combination with 120-h infusion of 5-fluorouracil in patients with metastatic colorectal carcinoma: Japan Clinical Oncology Group Study (JCOG9703)
Atsushi Ohtsu, Narikazu Boku, Takashi Yoshioka, et al.
International Journal of Clinical Oncology
|
March 15, 2012
Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer
Natsuko Hori, Satoru Iwasa, Hironobu Hashimoto, et al.
Page
of 30